Study on the acute toxicity of nano-hydroxyapatite

TANG Jinglong,WANG Shuo,WANG Jianyu,LIU Li,LI Jiage,YUAN Fuqiang,LU songfang,ZHOU Hongjiao,XI Tingfei
DOI: https://doi.org/10.3969/j.issn.1002-3208.2008.04.001
2008-01-01
Abstract:To explore the acute toxicity of nano-hydroxyapatite(nano-HAP),and establish a dosage regimen for subacute/subchronic and other toxicological studies as well as to provide primary information on the mode of translocation for nano-HAP in circulatory system.Acute toxicity test were carried out.70 Wistar rats were divided into 7 groups at random,control group used saline and 6 treated groups,their dosages used were 21.66mg/kg,29.97 mg/kg,41.49 mg/kg,57.42 mg/kg,79.48 mg/kg,110.39 mg/kg respectively,which were single treated by intravenous administration.During the 14 days experiment,the body weight and toxicity symptoms of all animals were recorded.All dead animals were immediately killed by cervical dislocation and then their brain,kidney,spleen,liver,heart,lung were excised to analyse the histopathological alterations.The results showed that the fifty percent lethal doses(LD50) of intravenous nano-HAP in rat were 51.79 mg/kg.According to histopathological analysis,thromboses may cause the death of the rats.The results of histopathological analysis also showed that some inflammatory cells were found in one rat's liver,which was treated under the lowest dose.These results suggested that when nano-HAP fully disperses in solution,nano-HAP particles could translocate to other organs,such as liver.Hence,it is necessary to study the biological safety of nano-HAP in details.
What problem does this paper attempt to address?